Figure 1S from Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma

Authors :: Christopher G. Wood
Charles A. Nicolette
Irina Y. Tcherepanova
Joe Horvatinovich
Marcus S. Norris
Ana Plachco
Alicia Gamble
Mark DeBenedette
Gennady Bratslavsky
William Lowrance
Daniel Vaena
Anil Kapoor
Viraj Master
David Y.T. Chen
Scott S. Tykodi
Robert G. Uzzo
Nizar M. Tannir
Robert A. Figlin
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Consort diagram

Full Text Access

Tools